“Poland is no longer an emerging market. It’s a partnering market.” Dr. Magdalena Kulczycka, founder of the Biotech Innovation Institute, is a molecular biologist with experience spanning academia, entrepreneurship, and venture capital. Her institute fosters biotech growth from lab to
“We invest emotionally and intellectually in their journey—when their product reaches patients, that’s our success too.” Janet Hoogstraate, CEO of NorthX Biologics, brings ~30 years of pharmaceutical experience spanning from preclinical development to GMP production for marketed products, with leadership
The relationship between pharmaceutical companies and their manufacturing partners is changing. At CPHI Frankfurt 2025, industry leaders outlined a new approach to CDMO selection and management during the talk, “CDMOs at a Crossroads: Scaling, Adapting, and Partnering for the Future.”
“CDMOs are partners with deep, extensive technical expertise that can be leveraged strategically—not just a restaurant where you pick from a menu.” Marta Kijanka, founder of MK Bioconsultancy, is a strategic project manager and CMC consultant who guides early-stage biotech
Tony Watson, Director of Procurement at Accord Healthcare, believes relationships are everything: “We spend our entire careers working on this network, but it can deliver so much more. If I could do one thing with CDMOs and our business support
How can integrated supply planning between sponsors and contract development and manufacturing organizations (CDMOs) improve resilience and cost control? This question has taken on new urgency as drug shortages in the U.S. continue to persist and geopolitical tensions reshape global
As the pharmaceutical industry grapples with geopolitical tensions, regulatory shifts, and technological disruption, the question of what constitutes a strong external partnership has never been more critical. We asked industry leaders across CDMOs, biotechs, and technology providers to share their
“Biotechs need flexibility and have limited budgets, while big pharma looks for long-term partnerships, reliability, scalability, and new technologies.” Luis Berrade, Senior Director of Global Biologics Testing Sales at Charles River Laboratories, has spent his career helping pharmaceutical and biotech
